PPARG and anal carcinoma: Meantime, prior studies suggested that thiazolidinediones and glucagon-like peptide-1 analogues were connected with cancer risk, which could further validate our findings that PPARG and GLP1R were associated with increased anal carcinoma and cardia cancer risk [60].